These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7453347)

  • 1. [Treatment of recurrent cervical cancer with doxorubicin in combination with methotrexate].
    Grundsell H; Johnsson JE; Mattsson W; Tropé C
    Lakartidningen; 1980 Oct; 77(40):3491-4. PubMed ID: 7453347
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of cervical carcinoma with adriamycin combined with methotrexate.
    Papavasiliou C; Pappas J; Aravantinos D; Kaskarelis D
    Cancer Treat Rep; 1978 Sep; 62(9):1387-8. PubMed ID: 688283
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin versus adriamycin and bleomycin in advanced epidermoid carcinoma of the cervix.
    Greenberg BR; Kardinal CG; Pajak TF; Bateman JR
    Cancer Treat Rep; 1977 Oct; 61(7):1383-4. PubMed ID: 73417
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
    Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
    Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced and recurrent squamous cell carcinoma of the cervix with combination doxorubicin and cyclophosphamide.
    Hanjani P; Bonnell S
    Cancer Treat Rep; 1980; 64(12):1363-5. PubMed ID: 6162557
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy for recurrent and metastatic cervical cancer.
    Tao X; Hu W; Ramirez PT; Kavanagh JJ
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S67-71. PubMed ID: 18533239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated liposomal doxorubicin in platinum-treated recurrent or metastatic cervical carcinoma.
    Ferrandina G; Lorusso D; Longo R; Testa AC; Scambia G
    Gynecol Oncol; 2005 Aug; 98(2):332-3. PubMed ID: 15907985
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
    Kastritis E; Bamias A; Bozas G; Koutsoukou V; Voulgaris Z; Vlahos G; Rodolakis A; Gika D; Papadimitriou C; Dimopoulos MA
    Gynecol Oncol; 2007 Feb; 104(2):372-6. PubMed ID: 17030353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of cervical cancer. An analysis of 18 cases].
    Morf P
    Gynakol Rundsch; 1980; 20(4):207-17. PubMed ID: 7194207
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracil.
    Malkasian GD; Decker DG; Green SJ; Edmonson JH; Jefferies JA; Webb MJ
    Gynecol Oncol; 1981 Apr; 11(2):235-9. PubMed ID: 7011913
    [No Abstract]   [Full Text] [Related]  

  • 11. Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.
    Guthrie D; Way S
    Obstet Gynecol; 1981 May; 57(5):677-8. PubMed ID: 7219919
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix.
    de Palo GM; Bajetta E; Luciani L; Musumeci R; Di Re F; Bonadonna G
    Cancer Chemother Rep; 1973; 57(4):429-35. PubMed ID: 4128423
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced carcinoma of the cervix with adriamycin and methotrexate combined.
    Guthrie D; Way S
    Obstet Gynecol; 1974 Oct; 44(4):586-9. PubMed ID: 4547341
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
    Umesaki N; Izumi R; Fushiki H; Hasegawa K; Kono I; Nishida M; Noguchi H; Okuda H; Sugimori H; Takizawa K; Udagawa Y; Yamamoto K; Tanaka T; Noda K
    Gynecol Oncol; 1999 Oct; 75(1):142-4. PubMed ID: 10502441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
    Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J
    J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for recurrent cervical cancer.
    Cadron I; Van Gorp T; Amant F; Leunen K; Neven P; Vergote I
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S113-8. PubMed ID: 17804044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
    Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.
    Omura GA
    J Natl Cancer Inst Monogr; 1996; (21):123-6. PubMed ID: 9023841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.